Latest filing published 08 Apr 2021 for abrdn World Healthcare Fund, €3,002.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 12 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -19.0%Entry US$17.07 · Close at T+365 US$13.83
- -15.1%Entry US$27.60 · Close at T+365 US$23.44
- -42.4%Entry US$29.86 · Close at T+365 US$17.19
- -16.2%Entry US$20.10 · Close at T+365 US$16.85
- +8.5%Entry US$10.94 · Close at T+365 US$11.87
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lucinda H. Stebbins: trading record in brief
Lucinda H. Stebbins has filed trades across 4 companies (mainly through SEC (Form 4)), most often in abrdn Healthcare Investors, abrdn Life Sciences Investors and abrdn World Healthcare Fund. In total, 16 filings cover trades dated from 27 December 2006 to 6 April 2021.
Market trades split into 12 purchases (€231k) and 1 sale (€18k). The net balance comes to €213k on the buying side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 3 share grants. 2021 to date brings 1 purchase and no sales.
Half of the purchases are above €14k and half below. Ninety days after publication, 12 purchases show a median change of -2.0%, with the price up in 50% of them. This is a record of the past, not a forecast.
The record was last updated on 8 April 2021 with a share grant (€3,002) in abrdn World Healthcare Fund. The last insider purchase was made public on 23 February 2021, 2,084 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lucinda H. Stebbins
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 250 shares@ US$14.2622.4% of flowShares of Beneficial InterestSEC:0001104659-21-048076:0
- 750 shares@ US$16.8077.6% of flowShares of Beneficial InterestSEC:0001104659-21-026885:0Canonical exit: 20 May 2021 (T+90)
- 1,000 shares@ US$28.17Shares of Beneficial InterestSEC:0001104659-15-048410:0Canonical exit: 27 Sept 2015 (T+90)
- 2,000 shares@ US$35.74Shares of Beneficial InterestSEC:0001104659-15-048411:0Canonical exit: 27 Sept 2015 (T+90)
- 1,000 shares@ US$20.07Shares of Beneficial InterestSEC:0001104659-14-084860:0Canonical exit: 3 Mar 2015 (T+90)
- 1,000 shares@ US$19.75Shares of Beneficial InterestSEC:0001104659-14-049426:0
- 1,400 shares@ US$25.04Shares of Beneficial InterestSEC:0001104659-14-049425:0
- 300 shares@ US$10.50Shares of beneficial interestSEC:0001236462-09-000002:0Canonical exit: 2 Dec 2009 (T+90)
- 200 shares@ US$10.51Shares of beneficial interestSEC:0001236462-09-000002:1Canonical exit: 2 Dec 2009 (T+90)
- 500 shares@ US$10.52Shares of beneficial interestSEC:0001236462-09-000002:2Canonical exit: 2 Dec 2009 (T+90)
- 1,500 shares@ US$8.14Shares of beneficial interestSEC:0001236462-09-000001:0Canonical exit: 16 Aug 2009 (T+90)
- 1,800 shares@ US$12.65Shares of beneficial interestSEC:0001236462-08-000002:0Canonical exit: 25 May 2008 (T+90)
- 2,000 shares@ US$13.12Shares of beneficial interestSEC:0001236462-08-000001:0
- 1,000 shares@ US$16.63Shares of Beneficial InterestSEC:0001236462-07-000002:0Canonical exit: 19 Nov 2007 (T+90)
- 3,000 shares@ US$14.98Shares of Beneficial InterestSEC:0001236462-07-000001:0Canonical exit: 10 May 2007 (T+90)
- 3,000 shares@ US$16.41H&Q Healthcare InvestorsSEC:0001236462-06-000004:0Canonical exit: 27 Mar 2007 (T+90)
16 of 16 declarations